PLATINUM Workhorse Trial
Platinum Chromium Everolimus-Eluting Clinical Experience
Study Objective: Evaluate the safety and effectiveness of the Promus PtCr EES Stent System* for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length; ≥ 2.50 mm to ≤ 4.25 mm in diameter compared to the Xience CoCr EES
Study Design: Prospective, Randomized, Controlled, Non-inferiority, Multicenter
Platform Influences Outcomes
Numerically Lower Ischemia-Driven TLR1
5-Year Clinical Results
Numerically Lower Event Rates1
5-Year Clinical Results
Significant Reduction In Unplanned Bail-out Stenting = $116 Savings / Procedure2, 3
1-Year Results
Submit Questions
Product Updates